![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 11, 7292-7301, March 12, 1999
From the Laboratory of Molecular Pharmacology and the
A Ser740
Mutation of a Conserved Serine Residue in a Quinolone-resistant
Type II Topoisomerase Alters the Enzyme-DNA and Drug
Interactions
, and
Laboratory of Medicinal Chemistry, Division of Basic Sciences,
NCI, National Institutes of Health, Bethesda, Maryland 20892-4255 and
the § Department of Molecular Pharmacology, St. Jude
Children's Research Hospital, Memphis, Tennessee 38105
Trp
mutation in yeast topoisomerase II (top2) and of the equivalent
Ser83 in gyrase results in resistance to quinolones and
confers hypersensitivity to etoposide (VP-16). We characterized the
cleavage complexes induced by the top2S740W in the human
c-myc gene. In addition to resistance to the
fluoroquinolone CP-115,953, top2S740W induced novel DNA
cleavage sites in the presence of VP-16, azatoxin, amsacrine, and
mitoxantrone. Analysis of the VP-16 sites indicated that the changes in
the cleavage pattern were reflected by alterations in base preference.
C at position
2 and G at position +6 were observed for the
top2S740W in addition to the previously reported C
1 and
G+5 for the wild-type top2. The VP-16-induced top2S740W
cleavage complexes were also more stable. The most stable sites had
strong preference for C
1, whereas the most reversible sites showed no
base preference at positions
1 or
2. Different patterns of DNA
cleavage were also observed in the absence of drug and in the presence
of calcium. These results indicate that the Ser740
Trp mutation alters the DNA recognition of top2,
enhances its DNA binding, and markedly affects its interactions with
inhibitors. Thus, residue 740 of top2 appears critical for both DNA and
drug interactions.
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
F. Mueller-Planitz and D. Herschlag DNA topoisomerase II selects DNA cleavage sites based on reactivity rather than binding affinity Nucleic Acids Res., June 28, 2007; 35(11): 3764 - 3773. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Gruger, J. L. Nitiss, A. Maxwell, E. L. Zechiedrich, P. Heisig, S. Seeber, Y. Pommier, and D. Strumberg A Mutation in Escherichia coli DNA Gyrase Conferring Quinolone Resistance Results in Sensitivity to Drugs Targeting Eukaryotic Topoisomerase II Antimicrob. Agents Chemother., December 1, 2004; 48(12): 4495 - 4504. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Leontiou, J. H. Lakey, and C. A. Austin Mutation E522K in Human DNA Topoisomerase II{beta} Confers Resistance to Methyl N-(4'-(9-acridinylamino)-phenyl)carbamate hydrochloride and Methyl N-(4'-(9-acridinylamino)-3-methoxy-phenyl) methane sulfonamide but Hypersensitivity to Etoposide Mol. Pharmacol., September 1, 2004; 66(3): 430 - 439. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Suda, Y. Ito, T. Imai, T. Kikumori, A. Kikuchi, Y. Nishiyama, S. Yoshida, and M. Suzuki The {alpha}4 residues of human DNA topoisomerase II{alpha} function in enzymatic activity and anticancer drug sensitivity Nucleic Acids Res., March 16, 2004; 32(5): 1767 - 1773. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Vilain, M. Tsai-Pflugfelder, A. Benoit, S. M. Gasser, and D. Leroy Modulation of drug sensitivity in yeast cells by the ATP-binding domain of human DNA topoisomerase II{alpha} Nucleic Acids Res., October 1, 2003; 31(19): 5714 - 5722. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Strumberg, J. L. Nitiss, J. Dong, J. Walker, M. C. Nicklaus, K. W. Kohn, J. G. Heddle, A. Maxwell, S. Seeber, and Y. Pommier Importance of the Fourth Alpha-Helix within the CAP Homology Domain of Type II Topoisomerase for DNA Cleavage Site Recognition and Quinolone Action Antimicrob. Agents Chemother., September 1, 2002; 46(9): 2735 - 2746. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Binaschi, R. Farinosi, M. E. Borgnetto, and G. Capranico In Vivo Site Specificity and Human Isoenzyme Selectivity of Two Topoisomerase II-poisoning Anthracyclines Cancer Res., July 1, 2000; 60(14): 3770 - 3776. [Abstract] [Full Text] |
||||
![]() |
M. E. Shea and H. Hiasa Distinct Effects of the UvrD Helicase on Topoisomerase- Quinolone-DNA Ternary Complexes J. Biol. Chem., May 5, 2000; 275(19): 14649 - 14658. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Strumberg, J. L. Nitiss, J. Dong, K. W. Kohn, and Y. Pommier Molecular Analysis of Yeast and Human Type II Topoisomerases. ENZYME-DNA AND DRUG INTERACTIONS J. Biol. Chem., October 1, 1999; 274(40): 28246 - 28255. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |